• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Atherosclerosis

September 4, 2013
Pharmaceutical Articles

Review: Hypertension and the Pathogenesis of Atherosclerosis

Hypertension (HTN) is defined as systolic blood pressure (BP) of 140 mmHg or higher or a diastolic BP of 90 mmHg or higher at the age of 20 years, and 160/95 mmHg at the age of 50 years[1]; however the Joint National Committee of

More
Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR
February 15, 2020

Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR

Convenience and large inventory remain key points of attraction for consumers, which

January 16, 2020

Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth

According to a report, the global atherosclerosis drugs market was valued at

Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR
Pharmaceutical News

Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR

February 15, 2020

Convenience and large inventory remain key points of attraction for consumers, which makes hospital pharmacies the primary distribution channel in

More
Pharmaceutical News

Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth

January 16, 2020

According to a report, the global atherosclerosis drugs market was valued at ~US$ 45.7 Bn in2018, and is expected to expand

More
Pharmaceutical Articles

Review: Hypertension and the Pathogenesis of Atherosclerosis

September 4, 2013
1

Hypertension (HTN) is defined as systolic blood pressure (BP) of 140 mmHg or higher or a diastolic BP of 90

More
  • APAC overview: trends, challenges, and possibilities for growth in the MarTech sector
  • Modernizing Therapeutic Cell Production
  • Neuraxpharm completes its presence in Benelux
  • Pharma Mirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase
  • Leg Veins: Why They Appear and How Vein Doctors Treat Them?

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop